A founding goal of TCF was realized as researchers published “Generation of a Biliary Tract Cancer Cell Line Atlas Identifies Molecular Subtypes and Therapeutic Targets“, in Cancer Discovery, a journal of the American Association for Cancer Research. The paper details identification of potential drug targets and novel disease subtypes through in-depth genetic and cellular analysis of a large collection of biliary tract cancer cell lines, paving the way for more personalized treatments.
